Balance Ophthalmics
Sioux Falls, US · Founded 2023 · Delaware corporation
Find your way into Balance Ophthalmics
Sign up to see every warm intro you have to Balance Ophthalmics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Balance Ophthalmics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Balance Ophthalmics develops ophthalmic medical technology for treating glaucoma, offering a non-pharmaceutical, non-surgical therapy that lowers intraocular pressure while patients sleep. Its products are intended for eye care professionals and glaucoma patients.
Founders & leadership
Balance Ophthalmics was founded in 2023 by John Berdahl.
JB
John BerdahlFounder
Board
AB
Alison BauerleinBoard director
PP
Philip PhillipsBoard director
ML
Matt LarsonBoard director
SR
Stuart RaetzmanBoard director
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 2 rounds · 2023–2024
▶$3.7MraisedOct 2024 · 29 investors · Other Health CareRule 506(b)
▶$3.7MraisedOct 2024 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Seph JensenExecutive Officer, Director
- Alison BauerleinDirector
- John BerdahlExecutive Officer, Director
- Philip PhillipsDirector
- Matt LarsonDirector
- Stuart RaetzmanDirector
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- Minimum investment
- $100K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$2MraisedAug 2023 · 8 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2023 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Philip PhillipsDirector
- John BerdahlExecutive Officer, Director
- Matt LarsonDirector
- Stuart RaetzmanDirector
- Seph JensenExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2M
- Minimum investment
- $10K
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Balance Ophthalmics.
Frequently asked questions
- What does Balance Ophthalmics do?
- Balance Ophthalmics develops ophthalmic medical technology for treating glaucoma, offering a non-pharmaceutical, non-surgical therapy that lowers intraocular pressure while patients sleep. Its products are intended for eye care professionals and glaucoma patients.
- Who founded Balance Ophthalmics?
- Balance Ophthalmics was founded by John Berdahl in 2023.
- How much funding has Balance Ophthalmics raised?
- Balance Ophthalmics has disclosed $5.7M raised across 2 rounds.
- Where is Balance Ophthalmics headquartered?
- Balance Ophthalmics is headquartered in Sioux Falls, US.


